{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Here are sentences with pharmaceutical terminology:  \n",
    "\n",
    "1. **Keytruda**, a **monoclonal antibody**, has transformed the landscape of **immuno-oncology**, offering new hope for patients with metastatic melanoma.  \n",
    "2. The **FDA** recently approved a **biosimilar** for **Humira**, addressing the growing demand for cost-effective treatments in **rheumatology**.  \n",
    "3. **CAR-T therapy** and **mRNA technology** are among the most groundbreaking innovations in **oncology**, enabling precision **therapeutics** for hard-to-treat cancers.  \n",
    "4. The company's **drug pipeline** includes multiple **biologics** in **Phase III clinical trials**, targeting diseases like lymphoma and multiple sclerosis.  \n",
    "5. Advances in **pharmacovigilance** have improved the monitoring of **adverse events** for therapies such as **Opdivo** and **Remdesivir**.  \n",
    "6. **Orphan drugs** developed for rare genetic disorders are often supported by incentives like **market exclusivity** and fast-track approval by the **EMA**.  \n",
    "7. High **bioavailability** and efficient **drug delivery systems**, such as lipid **nanoparticles**, have made **therapeutics** for heart failure more effective.  \n",
    "8. **Companion diagnostics** are essential for identifying patients who will benefit most from targeted **oncology** drugs like **Zytiga**.  \n",
    "9. A significant challenge in **pharmacokinetics** is ensuring that small molecule drugs maintain efficacy while minimizing **adverse events**.  \n",
    "10. The rise of **blockbuster drugs** like **Lipitor** has underscored the importance of **good manufacturing practices (GMP)** in ensuring global supply chain integrity.  \n",
    "____________________________________________________________________________________________________________________________________________________________________________"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "These are the results of previous experiments: **Input->Audio->Output**\n",
    "\n",
    "    Input 1: Keytruda, a monoclonal antibody, has transformed the landscape of immuno-oncology, offering new hope for patients with metastatic melanoma.\n",
    "    Output 1: Keytruda, a monoclonal antibody, has transformed the landscape of immuno oncology. Offering new hope for patients with metastatic melanoma.\n",
    "\n",
    "    Input 2: The FDA recently approved a biosimilar for Humira, addressing the growing demand for cost-effective treatments in rheumatology.\n",
    "    Output 2: The FDA recently approved a biosimilar for Humeira. Addressing the growing demand for cost-effective treatments in rheumatology.\n",
    "\n",
    "    Input 3: CAR-T therapy and mRNA technology are among the most groundbreaking innovations in oncology, enabling precision therapeutics for hard-to-treat cancers\n",
    "    Output 3: Carti therapy and mRNA technology are among the most groundbreaking innovations in oncology. Enabling precision therapeutics for hard-to-treat cancers.\n",
    "\n",
    "    Input 4: The company's drug pipeline includes multiple biologics in Phase III clinical trials, targeting diseases like lymphoma and multiple sclerosis.\n",
    "    Output 4: The company's drug pipeline includes multiple biologics in phase 3 clinical trials. Targeting diseases like lymphoma and multiple sclerosis.\n",
    "\n",
    "    Input 5: Advances in pharmacovigilance have improved the monitoring of adverse events for therapies such as Opdivo and Remdesivir.\n",
    "    Output 5: Advances in pharmacovigilance have improved the monitoring of adverse events for therapies such as. Op-Divo in Remdesivir.\n",
    "\n",
    "    Input 6: Orphan drugs developed for rare genetic disorders are often supported by incentives like market exclusivity and fast-track approval by the EMA\n",
    "    Output 6: Often drugs developed for rare genetic disorders are often supported by incentives like market. Exclusivity in fast track approval by the EMA.\n",
    "\n",
    "    Input 7: High bioavailability and efficient drug delivery systems, such as lipid nanoparticles, have made therapeutics for heart failure more effective.\n",
    "    Output 7: High bioavailability and efficient drug delivery systems. Such as lipod nanoparticles. Have need therapeutics for heart failure more effective.\n",
    "\n",
    "    Input 8: Companion diagnostics are essential for identifying patients who will benefit most from targeted oncology drugs like Zytiga.\n",
    "    Output 8: Companion diagnostics are essential for identifying patients who will benefit most from targeted. Oncology drugs like Zyteger.\n",
    "\n",
    "    Input 9: A significant challenge in pharmacokinetics is ensuring that small molecule drugs maintain efficacy while minimizing adverse events.\n",
    "    Output 9: A significant challenge in pharmacokinetics is ensuring that small molecule drugs maintain efficacy. While minimizing adverse events.\n",
    "\n",
    "    Input 10: The rise of blockbuster drugs like Lipitor has underscored the importance of good manufacturing practices (GMP) in ensuring global supply chain integrity. \n",
    "    Output 10: The rise of blockbuster drugs like Lippito has underscored the importance of good manufacturing. Practices, GNP, in ensuring global supply chain integrity.\n",
    "____________________________________________________________________________________________________________________________________________________________________________"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Clearly we have improve transcription for\n",
    "\n",
    "    Input 2\n",
    "    Input 3\n",
    "    Input 4\n",
    "    Input 5\n",
    "    Input 6\n",
    "    Input 7\n",
    "    Input 8\n",
    "    Input 10\n",
    "\n",
    "____________________________________________________________________________________________________________________________________________________________________________"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "import os\n",
    "import sys\n",
    "sys.path.append(os.getcwd()[:-10])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [],
   "source": [
    "text1 = \"Keytruda, a monoclonal antibody, has transformed the landscape of immuno-oncology, offering new hope for patients with metastatic melanoma.\"\n",
    "text2 = \"The FDA recently approved a biosimilar for Humira, addressing the growing demand for cost-effective treatments in rheumatology.\"\n",
    "text3 = \"CAR-T therapy and mRNA technology are among the most groundbreaking innovations in oncology, enabling precision therapeutics for hard-to-treat cancers\"\n",
    "text4 = \"The company's drug pipeline includes multiple biologics in Phase III clinical trials, targeting diseases like lymphoma and multiple sclerosis.\"\n",
    "text5 = \"Advances in pharmacovigilance have improved the monitoring of adverse events for therapies such as Opdivo and Remdesivir.\"\n",
    "text6 = \"Orphan drugs developed for rare genetic disorders are often supported by incentives like market exclusivity and fast-track approval by the EMA\"\n",
    "text7 = \"High bioavailability and efficient drug delivery systems, such as lipid nanoparticles, have made therapeutics for heart failure more effective.\"\n",
    "text8 = \"Companion diagnostics are essential for identifying patients who will benefit most from targeted oncology drugs like Zytiga.\"\n",
    "text9 = \"A significant challenge in pharmacokinetics is ensuring that small molecule drugs maintain efficacy while minimizing adverse events.\"\n",
    "text10 = \"The rise of blockbuster drugs like Lipitor has underscored the importance of good manufacturing practices (GMP) in ensuring global supply chain integrity. \"\n",
    "\n",
    "texts = [text1,text2,text3,text4,text5,text6,text7,text8,text9,text10]"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "transciption_0 is the Output that is mentioned above and it will be used as a benchmark to compare with the improved transcription"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [],
   "source": [
    "transcription_0 = [\"Keytruda, a monoclonal antibody, has transformed the landscape of immuno oncology. Offering new hope for patients with metastatic melanoma.\",\n",
    "                \"The FDA recently approved a biosimilar for Humeira. Addressing the growing demand for cost-effective treatments in rheumatology.\",\n",
    "                \"Carti therapy and mRNA technology are among the most groundbreaking innovations in oncology. Enabling precision therapeutics for hard-to-treat cancers.\",\n",
    "                \"The company's drug pipeline includes multiple biologics in phase 3 clinical trials. Targeting diseases like lymphoma and multiple sclerosis.\",\n",
    "                \"Advances in pharmacovigilance have improved the monitoring of adverse events for therapies such as. Op-Divo in Remdesivir.\",\n",
    "                \"Often drugs developed for rare genetic disorders are often supported by incentives like market. Exclusivity in fast track approval by the EMA.\",\n",
    "                \"High bioavailability and efficient drug delivery systems. Such as lipod nanoparticles. Have need therapeutics for heart failure more effective.\",\n",
    "                \"Companion diagnostics are essential for identifying patients who will benefit most from targeted. Oncology drugs like Zyteger.\",\n",
    "                \"A significant challenge in pharmacokinetics is ensuring that small molecule drugs maintain efficacy. While minimizing adverse events.\",\n",
    "                \"The rise of blockbuster drugs like Lippito has underscored the importance of good manufacturing. Practices, GNP, in ensuring global supply chain integrity.\",\n",
    "                ]"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# (a) Using initial-prompt for improving the transcription"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Idea: **Audio ---(whisper + initial_prompt)---> Improved Transcription**"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Load Whisper model\n",
    "from src.models.whisper import run"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Medical context prompt\n",
    "medical_prompt = \"\"\"\n",
    "This is a medical conversation involving pharmaceutical terms and healthcare terminology. The context includes discussions about drugs, medical fields, regulatory terms, safety practices, and scientific advancements. Key terms to recognize include:\n",
    "\n",
    "- Drug names such as Keytruda, Humira, Opdivo, Remdesivir, Zytiga, and Lipitor.\n",
    "- Medical fields like oncology, rheumatology, and immuno-oncology.\n",
    "- Regulatory bodies such as FDA and EMA.\n",
    "- Drug categories including biosimilars, biologics, orphan drugs, and blockbuster drugs.\n",
    "- Medical terms such as monoclonal antibody, therapeutics, pharmacokinetics, pharmacovigilance, and adverse events.\n",
    "- Scientific and technological concepts like CAR-T therapy, mRNA technology, drug delivery systems, and nanoparticles.\n",
    "- Industry terms such as drug pipeline, market exclusivity, Phase III clinical trials, and GMP (Good Manufacturing Practices).\n",
    "- Safety and diagnostics-related terms, including companion diagnostics and bioavailability.\n",
    "\n",
    "The conversation may include both clinical and regulatory contexts, so these terms should be prioritized for accurate transcription.\n",
    "\"\"\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 39,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Medical context prompt with phonetics\n",
    "medical_prompt_with_phonetics = \"\"\"\n",
    "This is a medical conversation involving pharmaceutical terms and healthcare terminology. The context includes discussions about drugs, medical fields, regulatory terms, safety practices, and scientific advancements.\n",
    "Use the exact spellings provided for specific terms below. Prioritize these spellings when transcribing.\n",
    "\n",
    "- Drug names:\n",
    "  - Keytruda (/kee-troo-dah/)\n",
    "  - Humira (/hyoo-mee-rah/)\n",
    "  - Opdivo (/op-dee-voh/)\n",
    "  - Remdesivir (/rem-des-uh-veer/)\n",
    "  - Zytiga (/zy-tee-gah/)\n",
    "  - Lipitor (/lip-ih-tor/)\n",
    "\n",
    "- Medical fields:\n",
    "  - Oncology (/on-kol-oh-jee/)\n",
    "  - Rheumatology (/roo-mah-tol-oh-jee/)\n",
    "  - Immuno-oncology (/im-yoo-noh on-kol-oh-jee/)\n",
    "\n",
    "- Regulatory bodies:\n",
    "  - FDA (/ef-dee-ay/)\n",
    "  - EMA (/ee-em-ay/)\n",
    "\n",
    "- Drug categories:\n",
    "  - Biosimilar (/bye-oh-sim-uh-lar/)\n",
    "  - Biologics (/bye-oh-lah-jiks/)\n",
    "  - Orphan drugs (/or-fan drugz/)\n",
    "  - Blockbuster drugs (/blok-bus-ter drugz/)\n",
    "\n",
    "- Medical terms:\n",
    "  - Monoclonal antibody (/mon-oh-klo-nuhl an-tih-bod-ee/)\n",
    "  - Therapeutics (/ther-ah-pew-tiks/)\n",
    "  - Pharmacokinetics (/farm-ah-ko-kin-et-iks/)\n",
    "  - Pharmacovigilance (/farm-ah-koh-vij-ih-luhns/)\n",
    "  - Adverse events (/ad-vers eh-vents/)\n",
    "\n",
    "- Scientific and technological concepts:\n",
    "  - CAR-T therapy (/car-tee ther-uh-pee/)\n",
    "  - mRNA technology (/em-ar-en-ay tek-nol-oh-jee/)\n",
    "  - Drug delivery systems (/drug de-liv-er-ee sis-temz/)\n",
    "  - Nanoparticles (/nan-oh-par-tih-klz/)\n",
    "\n",
    "- Industry terms:\n",
    "  - Drug pipeline (/drug py-plyne/)\n",
    "  - Market exclusivity (/mar-ket ex-kloo-siv-it-ee/)\n",
    "  - Phase III clinical trials (/fayz three klin-i-kal try-uhlz/)\n",
    "  - GMP (Good Manufacturing Practices) (/jee-em-pee/)\n",
    "\n",
    "- Safety and diagnostics-related terms:\n",
    "  - Companion diagnostics (/com-pan-yun dye-ag-nos-tiks/)\n",
    "  - Bioavailability (/bye-oh-uh-vay-luh-bil-ih-tee/)\n",
    "\n",
    "Ensure all transcriptions use these spellings exactly. Do not substitute with phonetic pronunciations or approximate terms.\n",
    "\"\"\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Loading the speech.\n",
      "Starting enhanced audio preprocessing for ../data/processed/voice_1.mp3\n",
      "Preprocessed audio exported to ../data/processed/temp2.wav\n",
      "Enhanced audio preprocessing completed.\n",
      "Starting audio transcription...\n",
      "Using device: cpu\n",
      "Loading Whisper Model.\n",
      "Performing the transciption\n",
      "Audio transcription completed.\n",
      "Loading the speech.\n",
      "Starting enhanced audio preprocessing for ../data/processed/voice_2.mp3\n",
      "Preprocessed audio exported to ../data/processed/temp2.wav\n",
      "Enhanced audio preprocessing completed.\n",
      "Starting audio transcription...\n",
      "Using device: cpu\n",
      "Loading Whisper Model.\n",
      "Performing the transciption\n",
      "Audio transcription completed.\n",
      "Loading the speech.\n",
      "Starting enhanced audio preprocessing for ../data/processed/voice_3.mp3\n",
      "Preprocessed audio exported to ../data/processed/temp2.wav\n",
      "Enhanced audio preprocessing completed.\n",
      "Starting audio transcription...\n",
      "Using device: cpu\n",
      "Loading Whisper Model.\n",
      "Performing the transciption\n",
      "Audio transcription completed.\n",
      "Loading the speech.\n",
      "Starting enhanced audio preprocessing for ../data/processed/voice_4.mp3\n",
      "Preprocessed audio exported to ../data/processed/temp2.wav\n",
      "Enhanced audio preprocessing completed.\n",
      "Starting audio transcription...\n",
      "Using device: cpu\n",
      "Loading Whisper Model.\n",
      "Performing the transciption\n",
      "Audio transcription completed.\n",
      "Loading the speech.\n",
      "Starting enhanced audio preprocessing for ../data/processed/voice_5.mp3\n",
      "Preprocessed audio exported to ../data/processed/temp2.wav\n",
      "Enhanced audio preprocessing completed.\n",
      "Starting audio transcription...\n",
      "Using device: cpu\n",
      "Loading Whisper Model.\n",
      "Performing the transciption\n",
      "Audio transcription completed.\n",
      "Loading the speech.\n",
      "Starting enhanced audio preprocessing for ../data/processed/voice_6.mp3\n",
      "Preprocessed audio exported to ../data/processed/temp2.wav\n",
      "Enhanced audio preprocessing completed.\n",
      "Starting audio transcription...\n",
      "Using device: cpu\n",
      "Loading Whisper Model.\n",
      "Performing the transciption\n",
      "Audio transcription completed.\n",
      "Loading the speech.\n",
      "Starting enhanced audio preprocessing for ../data/processed/voice_7.mp3\n",
      "Preprocessed audio exported to ../data/processed/temp2.wav\n",
      "Enhanced audio preprocessing completed.\n",
      "Starting audio transcription...\n",
      "Using device: cpu\n",
      "Loading Whisper Model.\n",
      "Performing the transciption\n",
      "Audio transcription completed.\n",
      "Loading the speech.\n",
      "Starting enhanced audio preprocessing for ../data/processed/voice_8.mp3\n",
      "Preprocessed audio exported to ../data/processed/temp2.wav\n",
      "Enhanced audio preprocessing completed.\n",
      "Starting audio transcription...\n",
      "Using device: cpu\n",
      "Loading Whisper Model.\n",
      "Performing the transciption\n",
      "Audio transcription completed.\n",
      "Loading the speech.\n",
      "Starting enhanced audio preprocessing for ../data/processed/voice_9.mp3\n",
      "Preprocessed audio exported to ../data/processed/temp2.wav\n",
      "Enhanced audio preprocessing completed.\n",
      "Starting audio transcription...\n",
      "Using device: cpu\n",
      "Loading Whisper Model.\n",
      "Performing the transciption\n",
      "Audio transcription completed.\n",
      "Loading the speech.\n",
      "Starting enhanced audio preprocessing for ../data/processed/voice_10.mp3\n",
      "Preprocessed audio exported to ../data/processed/temp2.wav\n",
      "Enhanced audio preprocessing completed.\n",
      "Starting audio transcription...\n",
      "Using device: cpu\n",
      "Loading Whisper Model.\n",
      "Performing the transciption\n",
      "Audio transcription completed.\n"
     ]
    }
   ],
   "source": [
    "transcription_1 = []\n",
    "for i in range(len(transcription_0)):\n",
    "\n",
    "    path = f\"../data/processed/voice_{i+1}.mp3\"\n",
    "\n",
    "    # Transcribe with phonetics\n",
    "    result = run(audio_file_path=path, initial_prompt=medical_prompt_with_phonetics)\n",
    "\n",
    "    transcription_1.append(result)\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 41,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Input: Keytruda, a monoclonal antibody, has transformed the landscape of immuno-oncology, offering new hope for patients with metastatic melanoma.\n",
      "Output: Keytruda, a monoclonal antibody, has transformed the landscape of immuno oncology. Offering new hope for patients with metastatic melanoma.\n",
      "Output:  Keytruder, a monoclinal antibody, has transformed the landscape of immuno-oncology. Offering new hope for patients with metastatic melanoma.\n",
      "\n",
      "Input: The FDA recently approved a biosimilar for Humira, addressing the growing demand for cost-effective treatments in rheumatology.\n",
      "Output: The FDA recently approved a biosimilar for Humeira. Addressing the growing demand for cost-effective treatments in rheumatology.\n",
      "Output:  The FDA recently approved a biosimilar for Humeira. Addressing the growing demand for cost-effective treatments in rheumatology.\n",
      "\n",
      "Input: CAR-T therapy and mRNA technology are among the most groundbreaking innovations in oncology, enabling precision therapeutics for hard-to-treat cancers\n",
      "Output: Carti therapy and mRNA technology are among the most groundbreaking innovations in oncology. Enabling precision therapeutics for hard-to-treat cancers.\n",
      "Output:  Carty therapy and mRNA technology are among the most groundbreaking innovations in oncology. Enabling precision therapeutics for hard-to-treat cancers.\n",
      "\n",
      "Input: The company's drug pipeline includes multiple biologics in Phase III clinical trials, targeting diseases like lymphoma and multiple sclerosis.\n",
      "Output: The company's drug pipeline includes multiple biologics in phase 3 clinical trials. Targeting diseases like lymphoma and multiple sclerosis.\n",
      "Output:  The company's drug pipeline includes multiple biologics in Phase III clinical trials. Targeting diseases like lymphoma and multiple sclerosis.\n",
      "\n",
      "Input: Advances in pharmacovigilance have improved the monitoring of adverse events for therapies such as Opdivo and Remdesivir.\n",
      "Output: Advances in pharmacovigilance have improved the monitoring of adverse events for therapies such as. Op-Divo in Remdesivir.\n",
      "Output:  Advances in pharmacovigilance have improved the monitoring of adverse events for therapies such as. Op-devote in Remdesivir.\n",
      "\n",
      "Input: Orphan drugs developed for rare genetic disorders are often supported by incentives like market exclusivity and fast-track approval by the EMA\n",
      "Output: Often drugs developed for rare genetic disorders are often supported by incentives like market. Exclusivity in fast track approval by the EMA.\n",
      "Output:  Often drugs developed for rare genetic disorders are often supported by incentives like market. Exclusivity in fast track approval by the EMER.\n",
      "\n",
      "Input: High bioavailability and efficient drug delivery systems, such as lipid nanoparticles, have made therapeutics for heart failure more effective.\n",
      "Output: High bioavailability and efficient drug delivery systems. Such as lipod nanoparticles. Have need therapeutics for heart failure more effective.\n",
      "Output:  High bioavailability and efficient drug delivery systems. Such as lipod nanoparticles. Have need therapeutics for heart failure more effective.\n",
      "\n",
      "Input: Companion diagnostics are essential for identifying patients who will benefit most from targeted oncology drugs like Zytiga.\n",
      "Output: Companion diagnostics are essential for identifying patients who will benefit most from targeted. Oncology drugs like Zyteger.\n",
      "Output:  Companion diagnostics are essential for identifying patients who will benefit most from targeted. On-coilogy drugs like Zyteger.\n",
      "\n",
      "Input: A significant challenge in pharmacokinetics is ensuring that small molecule drugs maintain efficacy while minimizing adverse events.\n",
      "Output: A significant challenge in pharmacokinetics is ensuring that small molecule drugs maintain efficacy. While minimizing adverse events.\n",
      "Output:  A significant challenge in pharmacokinetics is ensuring that small molecule drugs maintain efficacy. While minimizing adverse events.\n",
      "\n",
      "Input: The rise of blockbuster drugs like Lipitor has underscored the importance of good manufacturing practices (GMP) in ensuring global supply chain integrity. \n",
      "Output: The rise of blockbuster drugs like Lippito has underscored the importance of good manufacturing. Practices, GNP, in ensuring global supply chain integrity.\n",
      "Output:  The rise of blockbuster drugs like Lippito has underscored the importance of good manufacturing. Practices, GMP, in ensuring global supply chain integrity.\n",
      "\n"
     ]
    }
   ],
   "source": [
    "for i in range(len(texts)):\n",
    "    print(\"Input:\",texts[i])\n",
    "    print(\"Output:\",transcription_0[i])\n",
    "    print(\"Output:\",transcription_1[i])\n",
    "    print()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 38,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Input: Keytruda, a monoclonal antibody, has transformed the landscape of immuno-oncology, offering new hope for patients with metastatic melanoma.\n",
      "Output: Keytruda, a monoclonal antibody, has transformed the landscape of immuno oncology. Offering new hope for patients with metastatic melanoma.\n",
      "Output:  Keytruder, a monoclinal antibody, has transformed the landscape of immuno-oncology, offering new hope for patients with metastatic melanoma.\n",
      "__________________________________________________________________________________________________________________________\n",
      "Input: The FDA recently approved a biosimilar for Humira, addressing the growing demand for cost-effective treatments in rheumatology.\n",
      "Output: The FDA recently approved a biosimilar for Humeira. Addressing the growing demand for cost-effective treatments in rheumatology.\n",
      "Output:  The FDA recently approved a biosimilar for Humeira. Addressing the growing demand for cost-effective treatments in rheumatology.\n",
      "__________________________________________________________________________________________________________________________\n",
      "Input: CAR-T therapy and mRNA technology are among the most groundbreaking innovations in oncology, enabling precision therapeutics for hard-to-treat cancers\n",
      "Output: Carti therapy and mRNA technology are among the most groundbreaking innovations in oncology. Enabling precision therapeutics for hard-to-treat cancers.\n",
      "Output:  Carti therapy and mRNA technology are among the most groundbreaking innovations in oncology. Enabling precision therapeutics for hard-to-treat cancers.\n",
      "__________________________________________________________________________________________________________________________\n",
      "Input: The company's drug pipeline includes multiple biologics in Phase III clinical trials, targeting diseases like lymphoma and multiple sclerosis.\n",
      "Output: The company's drug pipeline includes multiple biologics in phase 3 clinical trials. Targeting diseases like lymphoma and multiple sclerosis.\n",
      "Output:  The company's drug pipeline includes multiple biologics in Phase III clinical trials. Targeting diseases like lymphoma and multiple sclerosis.\n",
      "__________________________________________________________________________________________________________________________\n",
      "Input: Advances in pharmacovigilance have improved the monitoring of adverse events for therapies such as Opdivo and Remdesivir.\n",
      "Output: Advances in pharmacovigilance have improved the monitoring of adverse events for therapies such as. Op-Divo in Remdesivir.\n",
      "Output:  Advances in pharmacovigilance have improved the monitoring of adverse events for therapies such as. OPDO in Remdesivir.\n",
      "__________________________________________________________________________________________________________________________\n",
      "Input: Orphan drugs developed for rare genetic disorders are often supported by incentives like market exclusivity and fast-track approval by the EMA\n",
      "Output: Often drugs developed for rare genetic disorders are often supported by incentives like market. Exclusivity in fast track approval by the EMA.\n",
      "Output:  Often drugs developed for rare genetic disorders are often supported by incentives like market. Exclusivity in fast track approval by the EMER.\n",
      "__________________________________________________________________________________________________________________________\n",
      "Input: High bioavailability and efficient drug delivery systems, such as lipid nanoparticles, have made therapeutics for heart failure more effective.\n",
      "Output: High bioavailability and efficient drug delivery systems. Such as lipod nanoparticles. Have need therapeutics for heart failure more effective.\n",
      "Output:  High bioavailability and efficient drug delivery systems. Such as lipod nanoparticles. Have need therapeutics for heart failure more effective.\n",
      "__________________________________________________________________________________________________________________________\n",
      "Input: Companion diagnostics are essential for identifying patients who will benefit most from targeted oncology drugs like Zytiga.\n",
      "Output: Companion diagnostics are essential for identifying patients who will benefit most from targeted. Oncology drugs like Zyteger.\n",
      "Output:  Companion diagnostics are essential for identifying patients who will benefit most from targeted. On-coilogy drugs like Zyteger.\n",
      "__________________________________________________________________________________________________________________________\n",
      "Input: A significant challenge in pharmacokinetics is ensuring that small molecule drugs maintain efficacy while minimizing adverse events.\n",
      "Output: A significant challenge in pharmacokinetics is ensuring that small molecule drugs maintain efficacy. While minimizing adverse events.\n",
      "Output:  A significant challenge in pharmacokinetics is ensuring that small molecule drugs maintain efficacy. While minimizing adverse events.\n",
      "__________________________________________________________________________________________________________________________\n",
      "Input: The rise of blockbuster drugs like Lipitor has underscored the importance of good manufacturing practices (GMP) in ensuring global supply chain integrity. \n",
      "Output: The rise of blockbuster drugs like Lippito has underscored the importance of good manufacturing. Practices, GNP, in ensuring global supply chain integrity.\n",
      "Output:  The rise of blockbuster drugs like Lippito has underscored the importance of good manufacturing. Practices, GMP, in ensuring global supply chain integrity.\n",
      "__________________________________________________________________________________________________________________________\n"
     ]
    }
   ],
   "source": [
    "for i in range(len(texts)):\n",
    "    print(\"Input:\",texts[i])\n",
    "    print(\"Output:\",transcription_0[i])\n",
    "    print(\"Output:\",transcription_1[i])\n",
    "    print(\"__________________________________________________________________________________________________________________________\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Input: Keytruda, a monoclonal antibody, has transformed the landscape of immuno-oncology, offering new hope for patients with metastatic melanoma.\n",
    "Output: Keytruda, a monoclonal antibody, has transformed the landscape of immuno oncology. Offering new hope for patients with metastatic melanoma.\n",
    "Output: keley- Truda, a monoclonal antibody, has transformed the landscape of immunovoncology, offering new hope for patients with metastatic melanoma.\n",
    "\n",
    "Input: The FDA recently approved a biosimilar for Humira, addressing the growing demand for cost-effective treatments in rheumatology.\n",
    "Output: The FDA recently approved a biosimilar for Humeira. Addressing the growing demand for cost-effective treatments in rheumatology.\n",
    "Output: ождения- The FDA recently approved a biosimilar for Humira. Addressing the growing demand for cost-effective treatments in rheumatology.\n",
    "\n",
    "Input: CAR-T therapy and mRNA technology are among the most groundbreaking innovations in oncology, enabling precision therapeutics for hard-to-treat cancers\n",
    "Output: Carti therapy and mRNA technology are among the most groundbreaking innovations in oncology. Enabling precision therapeutics for hard-to-treat cancers.\n",
    "Output:  CAR-T therapy and mRNA technology are among the most groundbreaking innovations in oncology. Enabling precision therapeutics for hard-to-treat cancers.\n",
    "\n",
    "Input: The company's drug pipeline includes multiple biologics in Phase III clinical trials, targeting diseases like lymphoma and multiple sclerosis.\n",
    "Output: The company's drug pipeline includes multiple biologics in phase 3 clinical trials. Targeting diseases like lymphoma and multiple sclerosis.\n",
    "Output:  The company's drug pipeline includes multiple biologics in Phase III clinical trials. Targeting diseases like LUMFOMER and Multiple Sclerosis.\n",
    "\n",
    "Input: Advances in pharmacovigilance have improved the monitoring of adverse events for therapies such as Opdivo and Remdesivir.\n",
    "Output: Advances in pharmacovigilance have improved the monitoring of adverse events for therapies such as. Op-Divo in Remdesivir.\n",
    "Output:  Advances in pharmacovigilance have improved the monitoring of adverse events for therapies such as Opdivo and Remdesivir.\n",
    "\n",
    "Input: Orphan drugs developed for rare genetic disorders are often supported by incentives like market exclusivity and fast-track approval by the EMA\n",
    "Output: Often drugs developed for rare genetic disorders are often supported by incentives like market. Exclusivity in fast track approval by the EMA.\n",
    "Output:  Symptoms such as drug-trips, and drug-trips, are often supported by incentives like market exclusivity and fast track approval by the EMA.\n",
    "\n",
    "Input: High bioavailability and efficient drug delivery systems, such as lipid nanoparticles, have made therapeutics for heart failure more effective.\n",
    "Output: High bioavailability and efficient drug delivery systems. Such as lipod nanoparticles. Have need therapeutics for heart failure more effective.\n",
    "Output:  hypertrophy, high bioavailability, and efficient drug delivery systems. Such as lipid nanoparticles, have made therapeutics for heart failure more effective.\n",
    "\n",
    "Input: Companion diagnostics are essential for identifying patients who will benefit most from targeted oncology drugs like Zytiga.\n",
    "Output: Companion diagnostics are essential for identifying patients who will benefit most from targeted. Oncology drugs like Zyteger.\n",
    "Output:  Companion diagnostics are essential for identifying patients who will benefit most from targeted. oncology drugs like Zytiga.\n",
    "\n",
    "Input: A significant challenge in pharmacokinetics is ensuring that small molecule drugs maintain efficacy while minimizing adverse events.\n",
    "Output: A significant challenge in pharmacokinetics is ensuring that small molecule drugs maintain efficacy. While minimizing adverse events.\n",
    "Output: świad- A significant challenge in pharmacokinetics is ensuring that small molecule drugs maintain efficacy, while minimizing adverse events.\n",
    "\n",
    "Input: The rise of blockbuster drugs like Lipitor has underscored the importance of good manufacturing practices (GMP) in ensuring global supply chain integrity. \n",
    "Output: The rise of blockbuster drugs like Lippito has underscored the importance of good manufacturing. Practices, GNP, in ensuring global supply chain integrity.\n",
    "Output: displaystyle- The rise of blockbuster drugs like Lipitor has underscored the importance of good manufacturing. Practices GMP, in ensuring global supply chain integrity."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# (b) Using phrase-matching algorithm for improving the transcription"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Collecting rapidfuzz\n",
      "  Downloading rapidfuzz-3.10.1-cp311-cp311-win_amd64.whl.metadata (11 kB)\n",
      "Downloading rapidfuzz-3.10.1-cp311-cp311-win_amd64.whl (1.6 MB)\n",
      "   ---------------------------------------- 0.0/1.6 MB ? eta -:--:--\n",
      "   -------------------------------------- - 1.6/1.6 MB 7.0 MB/s eta 0:00:01\n",
      "   ---------------------------------------- 1.6/1.6 MB 6.2 MB/s eta 0:00:00\n",
      "Installing collected packages: rapidfuzz\n",
      "Successfully installed rapidfuzz-3.10.1\n"
     ]
    }
   ],
   "source": [
    "# !pip install rapidfuzz"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "This method account each word seperately, so it will **FAIL** cause there are words that are being used in pairs."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 49,
   "metadata": {},
   "outputs": [],
   "source": [
    "from rapidfuzz import process\n",
    "\n",
    "# List of pharma terms\n",
    "pharma_terms_list = [\n",
    "    \"Keytruda\", \"monoclonal antibody\", \"immuno-oncology\", \"FDA\", \"biosimilar\",\n",
    "    \"Humira\", \"rheumatology\", \"CAR-T therapy\", \"mRNA technology\", \"oncology\",\n",
    "    \"therapeutics\", \"drug pipeline\", \"biologics\", \"Phase III clinical trials\",\n",
    "    \"pharmacovigilance\", \"adverse events\", \"Opdivo\", \"Remdesivir\", \"orphan drugs\",\n",
    "    \"market exclusivity\", \"EMA\", \"bioavailability\", \"drug delivery systems\",\n",
    "    \"nanoparticles\", \"companion diagnostics\", \"Zytiga\", \"pharmacokinetics\",\n",
    "    \"blockbuster drugs\", \"Lipitor\", \"GMP\", \"clinical trials\", \"gene therapy\",\n",
    "    \"biopharmaceutical\", \"small molecule drugs\", \"targeted therapy\", \"precision medicine\",\n",
    "    \"oncogenes\", \"tumor suppressor genes\", \"cytokines\", \"immune checkpoint inhibitors\",\n",
    "    \"T-cell therapy\", \"checkpoint blockade\", \"lymphoma\", \"multiple sclerosis\",\n",
    "    \"chemotherapy\", \"radiotherapy\", \"antiretroviral\", \"prodrug\", \"formulation\",\n",
    "    \"dosage form\", \"bioequivalence\", \"cytotoxic\", \"neoadjuvant therapy\"\n",
    "]\n",
    "\n",
    "# Correct transcription with fuzzy matching\n",
    "def correct_pharma_terms(transcription, terms):\n",
    "    corrected = []\n",
    "    test = []\n",
    "    for word in transcription.split():\n",
    "        result = process.extractOne(word, terms)\n",
    "        if result:\n",
    "            match, score = result[0], result[1]  # Extract match and score\n",
    "            corrected.append(match if score > 85 else word)  # Use threshold for corrections\n",
    "            test.append((word,corrected[-1]))\n",
    "        else:\n",
    "            corrected.append(word)  # Fallback for no match\n",
    "    print(test)\n",
    "    return \" \".join(corrected)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 50,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[('Keytruda,', 'Keytruda'), ('a', 'Humira'), ('monoclonal', 'monoclonal antibody'), ('antibody,', 'antibody,'), ('has', 'has'), ('transformed', 'transformed'), ('the', 'CAR-T therapy'), ('landscape', 'landscape'), ('of', 'of'), ('immuno', 'immuno-oncology'), ('oncology.', 'oncology'), ('Offering', 'Offering'), ('new', 'new'), ('hope', 'hope'), ('for', 'formulation'), ('patients', 'patients'), ('with', 'with'), ('metastatic', 'metastatic'), ('melanoma.', 'melanoma.')]\n",
      "[('The', 'The'), ('FDA', 'FDA'), ('recently', 'recently'), ('approved', 'approved'), ('a', 'Humira'), ('biosimilar', 'biosimilar'), ('for', 'formulation'), ('Humeira.', 'Humira'), ('Addressing', 'Addressing'), ('the', 'CAR-T therapy'), ('growing', 'growing'), ('demand', 'demand'), ('for', 'formulation'), ('cost-effective', 'cost-effective'), ('treatments', 'treatments'), ('in', 'drug pipeline'), ('rheumatology.', 'rheumatology')]\n",
      "[('Carti', 'Carti'), ('therapy', 'CAR-T therapy'), ('and', 'and'), ('mRNA', 'mRNA technology'), ('technology', 'mRNA technology'), ('are', 'are'), ('among', 'among'), ('the', 'CAR-T therapy'), ('most', 'most'), ('groundbreaking', 'groundbreaking'), ('innovations', 'innovations'), ('in', 'drug pipeline'), ('oncology.', 'oncology'), ('Enabling', 'Enabling'), ('precision', 'precision medicine'), ('therapeutics', 'therapeutics'), ('for', 'formulation'), ('hard-to-treat', 'hard-to-treat'), ('cancers.', 'cancers.')]\n",
      "[('The', 'The'), (\"company's\", \"company's\"), ('drug', 'drug pipeline'), ('pipeline', 'drug pipeline'), ('includes', 'includes'), ('multiple', 'multiple sclerosis'), ('biologics', 'biologics'), ('in', 'drug pipeline'), ('phase', 'phase'), ('3', '3'), ('clinical', 'Phase III clinical trials'), ('trials.', 'trials.'), ('Targeting', 'Targeting'), ('diseases', 'diseases'), ('like', 'like'), ('lymphoma', 'lymphoma'), ('and', 'and'), ('multiple', 'multiple sclerosis'), ('sclerosis.', 'multiple sclerosis')]\n",
      "[('Advances', 'Advances'), ('in', 'drug pipeline'), ('pharmacovigilance', 'pharmacovigilance'), ('have', 'have'), ('improved', 'improved'), ('the', 'CAR-T therapy'), ('monitoring', 'monitoring'), ('of', 'of'), ('adverse', 'adverse events'), ('events', 'adverse events'), ('for', 'formulation'), ('therapies', 'therapies'), ('such', 'such'), ('as.', 'as.'), ('Op-Divo', 'Op-Divo'), ('in', 'drug pipeline'), ('Remdesivir.', 'Remdesivir')]\n",
      "[('Often', 'Often'), ('drugs', 'orphan drugs'), ('developed', 'developed'), ('for', 'formulation'), ('rare', 'rare'), ('genetic', 'genetic'), ('disorders', 'disorders'), ('are', 'are'), ('often', 'often'), ('supported', 'supported'), ('by', 'by'), ('incentives', 'incentives'), ('like', 'like'), ('market.', 'market.'), ('Exclusivity', 'market exclusivity'), ('in', 'drug pipeline'), ('fast', 'fast'), ('track', 'track'), ('approval', 'approval'), ('by', 'by'), ('the', 'CAR-T therapy'), ('EMA.', 'EMA')]\n",
      "[('High', 'High'), ('bioavailability', 'bioavailability'), ('and', 'and'), ('efficient', 'efficient'), ('drug', 'drug pipeline'), ('delivery', 'drug delivery systems'), ('systems.', 'systems.'), ('Such', 'Such'), ('as', 'as'), ('lipod', 'lipod'), ('nanoparticles.', 'nanoparticles'), ('Have', 'Have'), ('need', 'need'), ('therapeutics', 'therapeutics'), ('for', 'formulation'), ('heart', 'heart'), ('failure', 'failure'), ('more', 'more'), ('effective.', 'effective.')]\n",
      "[('Companion', 'Companion'), ('diagnostics', 'companion diagnostics'), ('are', 'are'), ('essential', 'essential'), ('for', 'formulation'), ('identifying', 'identifying'), ('patients', 'patients'), ('who', 'who'), ('will', 'will'), ('benefit', 'benefit'), ('most', 'most'), ('from', 'from'), ('targeted.', 'targeted.'), ('Oncology', 'oncology'), ('drugs', 'orphan drugs'), ('like', 'like'), ('Zyteger.', 'Zyteger.')]\n",
      "[('A', 'FDA'), ('significant', 'significant'), ('challenge', 'challenge'), ('in', 'drug pipeline'), ('pharmacokinetics', 'pharmacokinetics'), ('is', 'is'), ('ensuring', 'ensuring'), ('that', 'that'), ('small', 'small molecule drugs'), ('molecule', 'small molecule drugs'), ('drugs', 'orphan drugs'), ('maintain', 'maintain'), ('efficacy.', 'efficacy.'), ('While', 'While'), ('minimizing', 'minimizing'), ('adverse', 'adverse events'), ('events.', 'events.')]\n",
      "[('The', 'The'), ('rise', 'rise'), ('of', 'of'), ('blockbuster', 'blockbuster drugs'), ('drugs', 'orphan drugs'), ('like', 'like'), ('Lippito', 'Lipitor'), ('has', 'has'), ('underscored', 'underscored'), ('the', 'CAR-T therapy'), ('importance', 'importance'), ('of', 'of'), ('good', 'good'), ('manufacturing.', 'manufacturing.'), ('Practices,', 'Practices,'), ('GNP,', 'GNP,'), ('in', 'drug pipeline'), ('ensuring', 'ensuring'), ('global', 'global'), ('supply', 'supply'), ('chain', 'chain'), ('integrity.', 'integrity.')]\n"
     ]
    }
   ],
   "source": [
    "transcription_2 = []\n",
    "for i in range(len(transcription_0)):\n",
    "    transcription_2.append(correct_pharma_terms(transcription_0[i], pharma_terms_list))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 48,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Input: Keytruda, a monoclonal antibody, has transformed the landscape of immuno-oncology, offering new hope for patients with metastatic melanoma.\n",
      "Output: Keytruda, a monoclonal antibody, has transformed the landscape of immuno oncology. Offering new hope for patients with metastatic melanoma.\n",
      "Output: Keytruda a monoclonal antibody, has transformed the landscape of immuno oncology Offering new hope for patients with metastatic melanoma.\n",
      "\n",
      "Input: The FDA recently approved a biosimilar for Humira, addressing the growing demand for cost-effective treatments in rheumatology.\n",
      "Output: The FDA recently approved a biosimilar for Humeira. Addressing the growing demand for cost-effective treatments in rheumatology.\n",
      "Output: The FDA recently approved a biosimilar for Humeira. Addressing the growing demand for cost-effective treatments in rheumatology\n",
      "\n",
      "Input: CAR-T therapy and mRNA technology are among the most groundbreaking innovations in oncology, enabling precision therapeutics for hard-to-treat cancers\n",
      "Output: Carti therapy and mRNA technology are among the most groundbreaking innovations in oncology. Enabling precision therapeutics for hard-to-treat cancers.\n",
      "Output: Carti therapy and mRNA technology are among the most groundbreaking innovations in oncology Enabling precision therapeutics for hard-to-treat cancers.\n",
      "\n",
      "Input: The company's drug pipeline includes multiple biologics in Phase III clinical trials, targeting diseases like lymphoma and multiple sclerosis.\n",
      "Output: The company's drug pipeline includes multiple biologics in phase 3 clinical trials. Targeting diseases like lymphoma and multiple sclerosis.\n",
      "Output: The company's drug pipeline includes multiple biologics in phase 3 clinical trials. Targeting diseases like lymphoma and multiple sclerosis.\n",
      "\n",
      "Input: Advances in pharmacovigilance have improved the monitoring of adverse events for therapies such as Opdivo and Remdesivir.\n",
      "Output: Advances in pharmacovigilance have improved the monitoring of adverse events for therapies such as. Op-Divo in Remdesivir.\n",
      "Output: Advances in pharmacovigilance have improved the monitoring of adverse events for therapies such as. Op-Divo in Remdesivir\n",
      "\n",
      "Input: Orphan drugs developed for rare genetic disorders are often supported by incentives like market exclusivity and fast-track approval by the EMA\n",
      "Output: Often drugs developed for rare genetic disorders are often supported by incentives like market. Exclusivity in fast track approval by the EMA.\n",
      "Output: Often drugs developed for rare genetic disorders are often supported by incentives like market. Exclusivity in fast track approval by the EMA.\n",
      "\n",
      "Input: High bioavailability and efficient drug delivery systems, such as lipid nanoparticles, have made therapeutics for heart failure more effective.\n",
      "Output: High bioavailability and efficient drug delivery systems. Such as lipod nanoparticles. Have need therapeutics for heart failure more effective.\n",
      "Output: High bioavailability and efficient drug delivery systems. Such as lipod nanoparticles Have need therapeutics for heart failure more effective.\n",
      "\n",
      "Input: Companion diagnostics are essential for identifying patients who will benefit most from targeted oncology drugs like Zytiga.\n",
      "Output: Companion diagnostics are essential for identifying patients who will benefit most from targeted. Oncology drugs like Zyteger.\n",
      "Output: Companion diagnostics are essential for identifying patients who will benefit most from targeted. Oncology drugs like Zyteger.\n",
      "\n",
      "Input: A significant challenge in pharmacokinetics is ensuring that small molecule drugs maintain efficacy while minimizing adverse events.\n",
      "Output: A significant challenge in pharmacokinetics is ensuring that small molecule drugs maintain efficacy. While minimizing adverse events.\n",
      "Output: A significant challenge in pharmacokinetics is ensuring that small molecule drugs maintain efficacy. While minimizing adverse events.\n",
      "\n",
      "Input: The rise of blockbuster drugs like Lipitor has underscored the importance of good manufacturing practices (GMP) in ensuring global supply chain integrity. \n",
      "Output: The rise of blockbuster drugs like Lippito has underscored the importance of good manufacturing. Practices, GNP, in ensuring global supply chain integrity.\n",
      "Output: The rise of blockbuster drugs like Lippito has underscored the importance of good manufacturing. Practices, GNP, in ensuring global supply chain integrity.\n",
      "\n"
     ]
    }
   ],
   "source": [
    "for i in range(len(texts)):\n",
    "    print(\"Input:\",texts[i])\n",
    "    print(\"Output:\",transcription_0[i])\n",
    "    print(\"Output:\",transcription_2[i])\n",
    "    print()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# (c) Using LLM layer after Transcription"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "estt",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.10"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
